Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 1315  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (901 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 » Introduction
 »  Materials and Me...
 » Results
 » Discussion
 » Conclusions
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    Viewed2971    
    Printed74    
    Emailed1    
    PDF Downloaded80    
    Comments [Add]    
    Cited by others 6    

Recommend this journal

 


 
Table of Contents    
ORIGINAL ARTICLE
Year : 2016  |  Volume : 64  |  Issue : 1  |  Page : 56-61

Rheumatoid arthritis and the risk of dementia: A systematic review and meta-analysis


1 Department of Internal Medicine, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Department of Medicine, Division of Rheumatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
2 Department of Medicine, Bassett Medical Center, Cooperstown, New York, USA

Date of Web Publication11-Jan-2016

Correspondence Address:
Patompong Ungprasert
Division of Rheumatology, Mayo Clinic, 200 First street SW, Rochester - 55905, Minnesota, USA

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.173623

Rights and Permissions

 » Abstract 

Background: The association between chronic inflammation and dementia has been identified in several epidemiologic studies. However, the data on rheumatoid arthritis (RA), one of the most common chronic inflammatory disorders, remains unclear.
Materials and Methods: We conducted a systematic review and meta-analysis of cohort, case–control, and cross-sectional studies that compared the risk of dementia in patients with RA versus non-RA controls. Data from each study were combined using random-effect, generic inverse variance method of DerSimonian and Laird to calculate the pooled risk ratio (RR) and 95% confidence interval (CI).
Results: Three cohort studies and two cross-sectional studies were identified and included in the meta-analysis. We found a significantly increased risk of dementia among patients with RA, with the pooled risk ratio of 1.61 (95% CI, 1.10–2.37). The statistical heterogeneity was high, with an I2 of 91%.
Conclusions: Our study demonstrated a statistically significant increase in the risk of dementia among patients with RA.


Keywords: Alzheimer's disease; dementia, epidemiology; meta-analysis; rheumatoid arthritis


How to cite this article:
Ungprasert P, Wijarnpreecha K, Thongprayoon C. Rheumatoid arthritis and the risk of dementia: A systematic review and meta-analysis. Neurol India 2016;64:56-61

How to cite this URL:
Ungprasert P, Wijarnpreecha K, Thongprayoon C. Rheumatoid arthritis and the risk of dementia: A systematic review and meta-analysis. Neurol India [serial online] 2016 [cited 2019 May 21];64:56-61. Available from: http://www.neurologyindia.com/text.asp?2016/64/1/56/173623



 » Introduction Top


Dementia is a common disorder in older adults characterized by a decline in the cognitive function of at least one domain. A prevalence study in 2000 suggested that at least 4.5 million older adults in the United States suffered from this ailment.[1] Alzheimer's disease (AD) is the most common subtype of dementia, followed by vascular dementia. Less common subtypes include dementia with Lewy bodies, frontotemporal dementia, and Parkinson's disease with dementia.[2] Several cardiovascular risk factors, including diabetes mellitus, hypertension, dyslipidemia, smoking, and obesity, have been linked to an increased risk of cognitive impairment and dementia.[3],[4]

The association between chronic inflammation and dementia has been identified in several epidemiologic studies.[5],[6] An autopsy study of patients with AD has found neuroinflammatory response in the cerebral cortex of patients with early-stage AD.[7] This evidence suggests that chronic inflammation could be another risk factor for developing dementia.

Rheumatoid arthritis (RA) is one of the most common chronic systemic inflammatory disorders, with an estimated incidence rate of 5–50 per 100,000 person-years.[8] Synovial joint is the primary site of involvement, though extra-articular diseases and cardiovascular complications from chronic inflammation are also well recognized.[9],[10]

Patients with RA might be at an increased risk of developing dementia. This study aimed to comprehensively review and summarize all available literature on the association between these two conditions.


 » Materials and Methods Top


Search strategy

Two investigators (P.U. and K.W.) independently searched for the published studies indexed in MEDLINE and EMBASE database from inception to August 2015 using the search strategy that comprised terms for RA and dementia as described in supplementary material 1. References of selected retrieved articles were also manually reviewed. The inclusion criteria were as follows: (1) Cross-sectional, case–control, or cohort study comparing the risk of dementia in subjects with and without RA; (2) odds ratio (OR), relative risk (RR), hazard ratio (HR), or standardized incidence ratio (SIR) with 95% confidence intervals (CI) were provided, or sufficient raw data to calculate those ratios and the corresponding 95% CI were provided; and, (3) participants without RA were used as controls in the cohort study and cross-sectional study, while participants without dementia were used as controls in the case–control study.

Each investigator noted earlier independently determined the study eligibility. Quality appraisal was also performed by the two investigators using Newcastle–Ottawa quality assessment scale,[11],[12] which assessed the study in three domains, including (1) the selection of the participants for each group, (2) the comparability between the groups, and (3) the ascertainment of the exposure (for case–control study) or the outcome of interest (for cohort and cross-sectional studies). The senior investigator (C.T.) oversaw this systematic review process and served as the deciding vote when the first two investigators had different decisions.

Data extraction

A standardized data collection form was used to extract the following information:First author's last name, title of the study, year of publication, year when the study was conducted, study design, country/state where the study was conducted, method used to identify and diagnose RA and dementia, average duration of follow-up (for cohort study), baseline demographic data of each group, confounders that were adjusted, and adjusted effect estimates with the corresponding 95% CIs. All investigators independently performed this data extraction, and the extracted data were cross-checked. Any discrepancy was evaluated by referring back to the original study.

Statistical analysis

Review Manager 5.3 software from the Cochrane Collaboration (London, United Kingdom) was used to calculate the pooled estimate effect. Point estimates and standard errors were extracted from each study and were combined by the generic inverse variance method of DerSimonian and Laird.[13] As we planned to combine data from different study designs, a high between-study variance was expected. Therefore, the random-effect model rather than a fixed-effect model was used. As the outcome of interest in this study was relatively infrequent, (odds ratio) OR of case–control study and cross-sectional study was used as an estimate for relative risk (RR) to calculate the pooled estimate. Statistical heterogeneity was assessed by Cochran's Q test and I 2 index. A value of I 2 index of 0%–25% represents insignificant heterogeneity, >25% but ≤50% represents low heterogeneity, >50% but ≤75% represents moderate heterogeneity, and >75% represents high heterogeneity.[14] Comprehensive Meta Analysis version 2.2 software (New Jersey, USA) was used to create funnel plot and to calculate Egger's linear regression test to assess the possibility of publication bias.[15]


 » Results Top


Our search strategy yielded 1,844 potentially relevant articles (1,573 articles from EMBASE and 271 articles from MEDLINE). After exclusion of 261 duplicated articles, 1,583 articles underwent title and abstract review. Of them, 1,422 articles were excluded in the first round of review, as they were case reports, editorials, review articles, correspondences, basic science studies, or interventional studies; 161 articles underwent a second round of abstract review, and 141 articles were excluded at this stage, as they were not conducted in patients with RA/dementia or did not report the association of interest, leaving 20 articles for a full-length article review. Nine articles were excluded because they were descriptive studies without a control group, while six case–control studies were excluded because they did not report the exposure of interest (RA). Three cohort studies and two cross-sectional studies met our eligibility criteria and were included in our data analyses.[16],[17],[18],[19],[20] [Figure 1] outlines our literature search and review process. The characteristics as well as the quality assessment of the included cohort and cross-sectional studies are illustrated in Table 1] and [Table 2], respectively.
Figure 1: Outline of our search methodology

Click here to view
Table 1: Characteristics and quality assessment of the cohort studies in the meta-analysis

Click here to view
Table 2: Characteristics and quality assessment of the cross-sectional studies in the meta-analysis

Click here to view


The pooled risk ratio of dementia in patients with RA versus the control subjects was 1.61 (95% CI, 1.10–2.37). The statistical heterogeneity was high, with an I 2 index of 91%. Subgroup analysis according to the study design revealed an increased pooled risk ratio in both subgroups even though the statistical significance was not reached in the cohort study subgroup (RR, 1.34; 95% CI, 0.93–1.94). The statistical heterogeneity was also markedly reduced when the point estimates were pooled according to the study design (I 2 index of 57% for cohort studies and 0% for cross-sectional studies). Forest plots of the overall analysis and subgroup analysis are illustrated in [Figure 2].
Figure 2: Forest plot of this meta-analysis

Click here to view


Evaluation for publication bias

Visualization of the funnel plot [Figure 3] did not provide suggestive evidence for publication bias, as the graph was symmetric. Moreover, there was no evidence of publication bias detected by Egger's regression test (P = 0.65).
Figure 3: Funnel plot

Click here to view



 » Discussion Top


Our study is the first study to provide a comprehensive evaluation on the association between RA and dementia. We found a statistically significant increase in the risk of dementia among patients with RA, with an overall 1.61-fold increased risk compared with non-RA controls. The relative risks from individual studies ranged from 1.15 to 2.77.

The pathophysiologic mechanisms underlying this increased risk are not well characterized. One possible explanation is related to the effect of chronic inflammation from RA on the brain, as several studies have suggested a significant role of inflammation in the pathogenesis of dementia. For example, increased proinflammatory cytokines have been shown to stimulate microglial activation and neuronal damage in vitro, and animal studies have demonstrated high levels of inflammatory cytokines in brains with neurodegeneration.[21],[22] Moreover, the association between dementia and elevated inflammatory markers has been found in several population-based epidemiologic studies.[23],[24]

Accelerated atherosclerosis from RA is another possible underlying mechanism, as atherosclerotic cardiovascular diseases are well-established risk factors for dementia.[3],[4] The role of inflammation in the pathogenesis of atherosclerosis is well recognized. Several in vivo and in vitro studies have demonstrated that endothelial cell injury from inflammatory cytokines, activated inflammatory cells, and oxidative stress promoted the progression of atherosclerosis.[25],[26],[27] Furthermore, epidemiologic studies have shown a higher incidence of cardiovascular disease among patients with autoimmune inflammatory disorders.[28],[29],[30],[31],[32]

Nonetheless, we acknowledge that there were some limitations in this study, and thus, the results should be interpreted with caution. First, most of the included studies were medical registry-based studies, which would raise a concern over coding inaccuracy and misclassification. The study by Husni et al.,[19] used a pharmaceutical database to verify the diagnosis of RA and dementia, which raised a serious concern of incompleteness of case identification because milder cases of RA and dementia, who did not require pharmacological interventions, would not be detected. To address this concern, we conducted a sensitivity analysis by excluding this study from the meta-analysis. The new pooled RR slightly decreased to 1.38 but remained statistically significant (95% CI, 1.00-1.93). Second, the statistical heterogeneity was high in this study. We believe that the difference in study design was the main source of heterogeneity, as subgroup analysis according to the study design revealed markedly reduced I 2 statistics for both subgroups. Third, this is a pooled analysis of observational studies, which can only demonstrate an association but not causality. Therefore, we cannot conclude that RA itself or some unknown confounders were accountable for the elevated risk.


 » Conclusions Top


In conclusion, our meta-analysis demonstrated a significantly increased risk of dementia among patients with RA, with 61% excess risk. Further studies are required to better understand the underlying pathogenesis and to develop optimal strategy to manage this increased risk.

Financial support and sponsorship

Nil.

Conflicts of interest

We do not have any financial or non-financial potential conflicts of interest.

 
 » References Top

1.
Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-22.  Back to cited text no. 1
    
2.
Morris JC. Dementia update 2003. Alzheimer Dis Assoc Disord 2003;17:245-58.  Back to cited text no. 2
    
3.
Dufouil C, Seshadri S, Chêne G. Cardiovascular risk profile in women and dementia. J Alzheimers Dis 2014;42(Suppl 4):S353-63.  Back to cited text no. 3
    
4.
Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005;62:1556-60.  Back to cited text no. 4
    
5.
Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002;52:168-74.  Back to cited text no. 5
    
6.
Sundelöf J, Kilander L, Helmersson J, Larsson A, Rönnemaa E, Degerman-Gunnarsson M, et al. Systemic inflammation and the risk of Alzheimer's disease and dementia: A prospective population-based study. J Alzheimers Dis 2009;18:79-87.  Back to cited text no. 6
    
7.
Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA. Neuroinflammation—An early event in both the history and pathogenesis of Alzheimer's disease. Neurodegener Dis 2010;7:38-41.  Back to cited text no. 7
    
8.
Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010;376:1094-108.  Back to cited text no. 8
    
9.
Ungprasert P, Srivali N, Spanuchart I, Thongprayoon C, Knight EL. Risk of venous thromboembolism in patients with rheumatoid arthritis: A systematic review and meta-analysis. Clin Rheumatol 2014;33:297-304.  Back to cited text no. 9
    
10.
Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: Incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722-7.  Back to cited text no. 10
    
11.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603-5.  Back to cited text no. 11
    
12.
Herzog R, Álvarez-Pasquin MJ, Díaz C, Del Barrio JL, Estrada JM, Gil Á. Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health 2013;13:154.  Back to cited text no. 12
    
13.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trial 1986;7:177-88.  Back to cited text no. 13
    
14.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.  Back to cited text no. 14
    
15.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.  Back to cited text no. 15
    
16.
Wallin K, Solomon A, Kåreholt I, Tuomilehto J, Soininen H, Kivipelto M. Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: A population-based study. J Alzheimers Dis 2012;31:669-76.  Back to cited text no. 16
    
17.
Lu K, Wang HK, Yeh CC, Huang CY, Sung PS, Wang LC, et al. Association between autoimmune disease and the risk of dementia. Biomed Res Int 2014;2014:861812.  Back to cited text no. 17
    
18.
Dregan A, Chowienczyk P, Gulliford MC. Are inflammation and related therapy associated with all-cause dementia in a primary care population? J Alzheimers Dis 2015;46:1039-47.  Back to cited text no. 18
    
19.
Husni ME, O'Rourke C, Moore T, Pillai J. Systemic inflammation in Alzheimer's disease: Relevance to patients with rheumatoid arthritis. Presented at the American College of Rheumatology Annual Scientific Meeting, Boston, Massachusetts, 14-19 November 2014. Abstract no. 1429.  Back to cited text no. 19
    
20.
Yesil NK, Ates A, Sahin K, Omma A, Yesil Y, Aslar ZO, et al. The prevalence of geriatric syndromes in patients with rheumatoid arthritis and relationship between disease activity. Presented at the Mediterranean Congress of Rheumatology, Istanbul, Turkey, 28-31 August 2014. Abstract no. P-094.  Back to cited text no. 20
    
21.
Campbell IL, Stalder AK, Chiang CS, Bellinger R, Heyser CJ, Steffensen S, et al. Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatry 1997;2:125-9.  Back to cited text no. 21
    
22.
Ho GJ, Drego R, Hakimian E, Masliah E. Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr Drug Targets Inflamm Allergy 2005;4:247-56.  Back to cited text no. 22
    
23.
Schram MT, Euser SM, de Craen AJ, Witteman JC, Frölich M, Hofman A, et al. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc 2007;55:708-16.  Back to cited text no. 23
    
24.
Rafnsson SB, Deary IJ, Smith FB, Whitman MC, Rumley A, Lowe GD, et al. Cognitive decline and markers of inflammation and hemostasis: The Edinburgh artery study. J Am Geriatr Soc 2007;55:700-7.  Back to cited text no. 24
    
25.
Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.  Back to cited text no. 25
    
26.
Montecucco F, Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford) 2009;48:11-22.  Back to cited text no. 26
    
27.
Niessner A, Sato K, Chaikof EL, Colmegna I, Goronzy JJ, Weyand CM. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in atherosclerotic plaque through interferon-alpha. Circulation 2006;114:2482-9.  Back to cited text no. 27
    
28.
Zoller B, Li X, Sundquist J, Sundquist K. Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: A nationwide follow-up study from Sweden. BMC Neurol 2012;12:41.  Back to cited text no. 28
    
29.
Ungprasert P, Charoenpong P, Ratanasrimetha P, Thongprayoon C, Cheungpasitporn W, Suksaranjit P. Risk of coronary artery disease in patients with systemic sclerosis: A systematic review and meta-analysis. Clin Rheumatol 2014:33:1099-104.  Back to cited text no. 29
    
30.
Ungprasert P, Suksaranjit P, Spanuchart I, Leeaphorn N, Permpalung N. Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis of observational studies. Semin Arthritis Rheum 2014;44:63-7.  Back to cited text no. 30
    
31.
Ungprasert P, Cheungpasitporn W, Wijarnpreecha K, Ahuja W, Ratanasrimetha P, Thongprayoon C. Risk of ischemic stroke in patients with polymyositis and dermatomyositis: A systematic review and meta-analysis. Rheumatol Int 2015;35:905-9.  Back to cited text no. 31
    
32.
Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of coronary artery disease in patients with ankylosing spondylitis: A systematic review and meta-analysis. Ann Transl Med 2015;3:51.  Back to cited text no. 32
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1], [Table 2]

This article has been cited by
1 Rheumatic diseases are associated with a higher risk of dementia: A nation-wide, population-based, case-control study
Kuan-Ting Chen,Yen-Chung Chen,Yu-Hsi Fan,Wen-Xiu Lin,Wun-Cin Lin,Yu-Hsun Wang,Lichi Lin,Jeng-Yuan Chiou,James C.-C. Wei
International Journal of Rheumatic Diseases. 2018; 21(2): 373
[Pubmed] | [DOI]
2 Rheumatoid arthritis and risk for Alzheimer’s disease: a systematic review and meta-analysis and a Mendelian Randomization study
Stefania Policicchio,Aminah Noor Ahmad,John Francis Powell,Petroula Proitsi
Scientific Reports. 2017; 7(1)
[Pubmed] | [DOI]
3 Rheumatic diseases and autoimmune vascular dementia
Fabiola Atzeni,Nicolò Pipitone,Luca Iaccarino,Ignazio Francesco Masala,Ronen Weiss,Alessandra Alciati,Andrea Doria,Joab Chapmanand,Piercarlo Sarzi-Puttini
Autoimmunity Reviews. 2017; 16(12): 1265
[Pubmed] | [DOI]
4 DMARD use is associated with a higher risk of dementia in patients with rheumatoid arthritis: A propensity score-matched case–control study
Ming-Hsien Chou,Jong-Yi Wang,Cheng-Li Lin,Wei-Sheng Chung
Toxicology and Applied Pharmacology. 2017; 334: 217
[Pubmed] | [DOI]
5 MiR-146a modulates macrophage polarization in systemic juvenile idiopathic arthritis by targeting INHBA
Dan Li,Mingyue Duan,Yuan Feng,Lingling Geng,Xiaoqing Li,Wanggang Zhang
Molecular Immunology. 2016; 77: 205
[Pubmed] | [DOI]
6 Rheumatoid Arthritis Was Negatively Associated with Alzheimer’s Disease: A Population-Based Case-Control Study
Li-Ting Kao,Jiunn-Horng Kang,Herng-Ching Lin,Chung-Chien Huang,Hsin-Chien Lee,Shiu-Dong Chung,Ornit Chiba-Falek
PLOS ONE. 2016; 11(12): e0168106
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow